Navigation Links
Beike Biotechnology Invests in Leading Japanese Regenerative Medicine Co., Biomaster Inc.
Date:11/5/2009

SHENZHEN, China, Nov. 5 /PRNewswire-Asia/ -- Shenzhen Beike Biotechnology Co. Ltd. ( http://www.beikebiotech.com ), China's leading stem cell research and regenerative medicine company, announced that it has entered into an agreement with Yokohama-based Biomaster Inc. ( http://www.biomaster.jp ) for investment in its advanced technologies. Biomaster specializes in research and commercialization of adipose-based stem cell therapies. Beike, along with two investment companies, has taken a significant share in Biomaster, secured a seat on the board, and is involved in the company's strategic positioning in preparation for an eventual IPO.

Since its inception in 2002, Biomaster has been a leading innovator in the field of adipose-derived stem cell regenerative technology. The company developed its proprietary Cell-Assisted Lipotransfer (CAL) procedure through joint research with the Plastic and Reconstructive Surgery Department at the University of Tokyo's Graduate School of Medicine. Biomaster's scientists have published ten articles in leading international journals related to stem cell technology.

Beike Biotechnology offers Biomaster a strategic launch pad for its technologies through its extensive clinical and research networks in China, Southeast Asia and Central America.

"This deal has created a powerful partnership that plays to our companies' respective advantages," stated Shoko Murase, Ph.D, president of Biomaster. "Biomaster is uniquely positioned as the only facility allowed by law to offer stem-cell based therapy to the Japanese public. From a healthcare standpoint, our partnership with Beike will extend our services to patients at Beike's affiliated clinical research institutes in China and worldwide. Biomaster's R&D will also benefit from Beike's wide network of research laboratories, international pa
'/>"/>

SOURCE Shenzhen Beike Biotechnology Co. Ltd.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. Spectrum Pharmaceuticals to Present at the Biotechnology Industry Organization Investor Forum
2. MichBio Announces Formation of Biotechnology Legislative Caucus
3. Not just humans benefit from animal biotechnology
4. UCLA, Tokyo University nanobiotechnology symposium at UCLA to highlight advances in nanomedicine
5. Biotech Company Builder Papadopoulos Says Investment in Innovation Needed to Advance Drug Pipeline at Massachusetts Biotechnology Councils Ninth Annual MASS Opportunities Investment Conference
6. Biotechnology Builds a New Heart
7. BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
8. Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
9. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
10. MAP Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
11. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Palo Alto Networks(TM), the network security ... its PA-4000 Series next-generation firewalls for accurate threat ... visibility and control over applications such as peer-to-peer ... national university with eight facilities on five campuses. ... a number of academic schools and institutions throughout ...
(Date:12/15/2009)... 15 Vitech Systems Group, a leading ... (CRM) software, announced today that it has completed ... the Screen Actors Guild-Producers Pension & Health Plans ... service capabilities to SAG-PH call center personnel in ... installed using Vitech,s V3 Benefits Administration System which ...
(Date:12/15/2009)... lower strength than needed for protection, CDC says, , , ... doses of H1N1 swine flu vaccine have been recalled ... some potency, federal health officials said Tuesday. , According ... the company,s routine testing of the vaccine for children ... four batches had lower than required potency levels. "This ...
(Date:12/15/2009)... Dec. 15 Knowledge ... the pharmaceutical and bio-tech research market with ... Over the past 11 years CMR has ... Consulting Network (PCN®), which now includes 70,000 ... both primary care and hard-to-reach specialties. ...
(Date:12/15/2009)... following are the remarks by Lanny A. ... at the Medicare Fraud Strike Force press conference: ... for the enormous effort everyone at HHS is ... our Departments have and will continue to accomplish ... progress in fighting Medicare fraud in South Florida, ...
Breaking Medicine News(10 mins):Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 2Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 3Health News:Screen Actors Guild - Producers Pension & Health Plans Live on New CRM Solution 2Health News:Large Recall of Children's Swine Flu Vaccine 2Health News:Knowledge Networks Expands in Pharma Research With Acquisition of CMR 2Health News:Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference 2Health News:Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference 3
... New Poll Finds Californians Overwhelmingly Oppose Mandatory Health,Insurance, ... Calif., Jan. 15 The following,is being issued ... What:, At a press conference, a Massachusetts ... will discuss his plight and why,Californians should not ...
... Nancy Pelosi and,senior House Democrats hosted a health ... in public policy, academia, business, medicine,with key legislators ... our health care,system., "As Americans, concerns grow ... and loss of coverage, the New Direction Congress ...
... Physicians Service,Insurance Corporation (WPS) filed a lawsuit in Milwaukee ... WPS,s contractual,relationship with HealthEOS by MultiPlan, an independent primary ... terms of its contract with,WPS. This action was taken ... face with Aurora and HealthEOS to resolve these issues ...
... to data,from the 2000 US Census, Pennsylvania,s ... United States behind Florida. Widener University, in,conjunction ... "The Widener Elder Pennsylvanian Survey," aimed at ... talked to baby boomers and,centenarians about their ...
... depression, anxiety more likely to have children with airway ... born to mothers who have persistent depression or anxiety ... suggests. , Canadian researchers report a 25 percent increase ... exposed to maternal distress from birth to age 7. ...
... − Researchers at Lombardi Comprehensive Cancer Center at Georgetown ... as cyclin D1 may be the Achilles heel for ... which is the most common type of breast cancer. ... the journal Oncogene, investigators say the findings support testing ...
Other Medicine News:Health News:Massachusetts Teacher Facing Unaffordable Mandatory Health Insurance Speaks Out Against CA Mandate Proposal 2Health News:Pelosi, Democrats Host Health Care Forum This Morning 2Health News:Pelosi, Democrats Host Health Care Forum This Morning 3Health News:Pelosi, Democrats Host Health Care Forum This Morning 4Health News:Wisconsin Physicians Service Insurance Corporation Files Suit Against Aurora Health Care and HealthEOS 2Health News:The Widener University 'Elder Pennsylvanian Survey' Finds Pennsylvania's Baby Boomers Anticipate Working Longer, Retiring Later to Help Offset Looming Health Care Costs 2Health News:The Widener University 'Elder Pennsylvanian Survey' Finds Pennsylvania's Baby Boomers Anticipate Working Longer, Retiring Later to Help Offset Looming Health Care Costs 3Health News:The Widener University 'Elder Pennsylvanian Survey' Finds Pennsylvania's Baby Boomers Anticipate Working Longer, Retiring Later to Help Offset Looming Health Care Costs 4Health News:Maternal Distress Raises Risk of Childhood Asthma 2Health News:Maternal Distress Raises Risk of Childhood Asthma 3Health News:Findings point to molecular 'Achilles heel' for half of breast cancer tumors 2Health News:Findings point to molecular 'Achilles heel' for half of breast cancer tumors 3
(Date:12/15/2009)... Certified healthcare providers who have already immunized patients ... flu virus may now offer the vaccine to ... announced today. ,, Pennsylvania is expanding the ... million doses of vaccine have been allocated to ... the priority groups. ,, "Many certified providers have ...
(Date:12/15/2009)... Dec. 15 Reportlinker.com announces ... is available in its catalogue: ,, ... Industry in the U.S. and its ... ,, http://www.reportlinker.com/p0167745/Surgical-and-Medical-Instrument-Manufacturing-Industry-in-the-US-and-its-International-Trade-[Q4-2009-Edition].html ,, The ... and Medical Instrument Manufacturing Industry report ...
(Date:12/15/2009)... NEW YORK, Dec. 15 ... research report is available in its ... A strategic assessment of the competitive ... highest priority management responsibilities, the task ... profitability. Timely and factual competitive intelligence ...
Breaking Medicine Technology:Department of Health Urges Expanded H1N1 Vaccination Efforts to Include All Patients 2Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 2Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 3Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 4Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 5Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 6Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 7Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 8Reportlinker Adds Top Ten World's Leading Orthopedics Companies 2Reportlinker Adds Top Ten World's Leading Orthopedics Companies 3Blood Test May Spot Pancreatic Cancer Early 55921 1Blood Test May Spot Pancreatic Cancer Early 55921 2Inhibition of NF kappa B a key inflammatory protein reduced radiation toxicity in zebrafish 55919 1Inhibition of NF kappa B a key inflammatory protein reduced radiation toxicity in zebrafish 55919 2Promising new target emerges for autoimmune diseases 55916 1Promising new target emerges for autoimmune diseases 55916 2Promising new target emerges for autoimmune diseases 55916 3
... 11, 2007,/PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. today,provided ... currently in ongoing,Phase 2 clinical trials in ... lymphoma patients. R788 is a novel,oral syk ... mast cells,macrophages and B-cells that promote swelling, ...
... WIRE)--Apr 11, 2007 - New data,supporting the clinical ... investigational oral protease inhibitors for the,treatment of hepatitis ... 42nd Annual Meeting of the European Association for ... week. In total, nine,abstracts related to telaprevir have ...
Other Medicine Technology:Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP,Rheumatoid Arthritis and Lymphoma 2Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP,Rheumatoid Arthritis and Lymphoma 3Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP,Rheumatoid Arthritis and Lymphoma 4Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 2Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 3Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 4Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 5Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 6
... of Protein C Activity by ... free of Protein C; highly ... contortrix venom for specific activation ... an activator selected specially for ...
Immuno-turbidimetric Assay for Antithrombin III Antigen. Suspension of microlatex particles coated with specific antibodies....
Immuno-turbidimetric Assay for Protein S Antigen. Suspension of microlatex particles coated with specific antibodies....
Immuno-turbidimetric assay for Free Protein Sby STA© Analyzers. Suspension of microparticles coated with monoclonal antibodies to Free Protein S....
Medicine Products: